drugset / Trial / NCT06828874
A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria
Phase 4
Completed
696 enrolled
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
RandomizedParallel-groupSingle-blindTreatment
Summary
Anaerobic infections are very common in clinical practice. Poor control of anaerobic infections in patients undergoing abdominal surgery may lead to the occurrence of complications. The aim of this study is to explore the efficacy and safety of Levornidazole Phosphate Disodium for Injection in the treatment of patients with postoperative intra-abdominal infections caused by anaerobic bacteria.
Timeline
- Start
- 2023-05-10
- Primary completion
- 2024-09-23
- Completion
- 2024-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levornidazole | Unknown | 1 g | Intravenous |
| Comparator | Ornidazole | Other / unclassified | 0.5 g | Intravenous |